ReviewFrontiers in pharmacology2022

From Rate-Limiting Enzyme to Therapeutic Target: The Promise of NAMPT in Neurodegenerative Diseases.

Yumeng Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.